⌘K

Home/Filings/4/0000899243-21-036132

4//SEC Filing

Cavalier Jason 4

Accession 0000899243-21-036132

CIK 0001327273other

View on SEC.gov Company Profile

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 5:44 PM ET

Size

5.6 KB

Accession

0000899243-21-036132

Insider Transaction Report

Form 4

Period: 2021-09-13

Lyra Therapeutics, Inc.LYRA

Chief Financial Officer

Transactions

Award
Stock Options (Right to Buy)
2021-09-13+104,000→ 104,000 total
Exercise: $8.22Exp: 2031-09-12→ Common Stock (104,000 underlying)

Footnotes (1)

[F1]This option vests and becomes exercisable as to 25% of the underlying shares on September 13, 2022 and in 36 substantially equal monthly installments thereafter.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Lyra Therapeutics, Inc.

CIK 0001327273

Entity typeother

Related Parties

1

filerCIK 0001883290

Filing Metadata

Form type: 4
Filed: Sep 14, 8:00 PM ET
Accepted: Sep 15, 5:44 PM ET
Size: 5.6 KB

View on SEC.gov